S
ST Pharm Co Ltd
KOSDAQ:237690
ST Pharm Co Ltd
KOSDAQ:237690
Price:
146 700
KRW
-0.68%
Market Cap:
₩3T
Balance Sheet
Balance Sheet Decomposition
ST Pharm Co Ltd
ST Pharm Co Ltd
Balance Sheet Decomposition is not available for
ST Pharm Co Ltd
ST Pharm Co Ltd
Balance Sheet
ST Pharm Co Ltd
ST Pharm Co Ltd
Currency: KRW
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
3 144
|
2 443
|
11 804
|
55 196
|
72 301
|
47 709
|
12 823
|
38 625
|
39 203
|
50 201
|
50 097
|
63 405
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
12 748
|
29 921
|
27 348
|
50 201
|
50 097
|
63 402
|
|
| Cash Equivalents |
3 144
|
2 443
|
11 804
|
55 196
|
72 301
|
47 709
|
75
|
8 704
|
11 855
|
0
|
0
|
4
|
|
| Short-Term Investments |
1 150
|
0
|
0
|
60 000
|
60 000
|
60 000
|
52 216
|
102 011
|
54 013
|
0
|
40 000
|
57 519
|
|
| Total Receivables |
18 729
|
19 212
|
16 636
|
17 968
|
30 279
|
17 298
|
35 951
|
46 762
|
64 448
|
97 871
|
122 627
|
69 976
|
|
| Accounts Receivables |
17 915
|
15 239
|
13 234
|
13 671
|
30 155
|
15 737
|
35 572
|
45 515
|
63 248
|
94 350
|
121 290
|
68 703
|
|
| Other Receivables |
814
|
3 973
|
3 402
|
4 297
|
124
|
1 561
|
379
|
1 247
|
1 200
|
3 522
|
1 336
|
1 273
|
|
| Inventory |
29 870
|
34 961
|
58 710
|
91 371
|
57 975
|
40 659
|
40 925
|
45 401
|
80 809
|
107 623
|
120 736
|
126 963
|
|
| Other Current Assets |
1 571
|
155
|
8 629
|
340
|
4 650
|
1 632
|
2 237
|
2 813
|
5 668
|
7 539
|
14 918
|
12 215
|
|
| Total Current Assets |
54 465
|
56 771
|
95 779
|
224 875
|
225 205
|
167 299
|
144 152
|
235 613
|
244 142
|
263 234
|
348 378
|
330 078
|
|
| PP&E Net |
45 038
|
63 759
|
134 099
|
138 430
|
151 580
|
169 069
|
170 980
|
175 634
|
210 190
|
257 885
|
280 105
|
338 695
|
|
| PP&E Gross |
45 038
|
63 759
|
134 099
|
138 430
|
151 580
|
169 069
|
170 980
|
175 634
|
210 190
|
257 885
|
280 105
|
338 695
|
|
| Accumulated Depreciation |
38 822
|
42 175
|
47 284
|
55 900
|
60 453
|
68 630
|
96 349
|
109 232
|
116 462
|
126 187
|
146 440
|
170 258
|
|
| Intangible Assets |
939
|
829
|
1 092
|
1 080
|
1 211
|
1 407
|
1 310
|
1 952
|
4 164
|
3 532
|
3 513
|
5 933
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
7 791
|
8 044
|
8 455
|
8 947
|
9 950
|
10 599
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
12 180
|
16 185
|
0
|
1 037
|
471
|
1 059
|
3 006
|
7 756
|
13 264
|
11 492
|
17 749
|
23 396
|
|
| Other Long-Term Assets |
3 185
|
4 829
|
1 397
|
2 357
|
3 037
|
6 671
|
13 370
|
16 572
|
18 351
|
25 563
|
15 741
|
13 174
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
7 791
|
8 044
|
8 455
|
8 947
|
9 950
|
10 599
|
|
| Total Assets |
115 806
N/A
|
142 373
+23%
|
232 367
+63%
|
367 779
+58%
|
381 504
+4%
|
345 505
-9%
|
340 610
-1%
|
445 570
+31%
|
498 565
+12%
|
570 652
+14%
|
675 436
+18%
|
721 876
+7%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
5 060
|
4 200
|
10 862
|
13 689
|
3 111
|
3 086
|
7 164
|
4 694
|
12 865
|
18 095
|
17 661
|
10 646
|
|
| Accrued Liabilities |
3 160
|
3 840
|
4 507
|
4 700
|
3 078
|
2 503
|
2 611
|
3 097
|
6 558
|
9 365
|
8 264
|
1 586
|
|
| Short-Term Debt |
8 283
|
32 500
|
32 500
|
0
|
0
|
0
|
0
|
0
|
0
|
20 000
|
20 878
|
30 000
|
|
| Current Portion of Long-Term Debt |
39 849
|
38 668
|
16 475
|
1 383
|
20
|
20
|
443
|
894
|
15 587
|
95 333
|
9 372
|
43 375
|
|
| Other Current Liabilities |
3 965
|
3 240
|
43 884
|
31 702
|
22 430
|
4 345
|
6 009
|
9 925
|
40 355
|
36 431
|
27 570
|
47 674
|
|
| Total Current Liabilities |
60 318
|
82 447
|
108 227
|
51 473
|
28 638
|
9 954
|
16 227
|
18 610
|
75 365
|
179 224
|
83 745
|
133 281
|
|
| Long-Term Debt |
195
|
176
|
10 156
|
137
|
117
|
98
|
15 551
|
126 033
|
91 930
|
19 188
|
161 832
|
44 767
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
2 387
|
1 425
|
3 058
|
3 471
|
2 356
|
141
|
|
| Other Liabilities |
1 587
|
2 571
|
3 110
|
2 924
|
1 667
|
3 885
|
5 622
|
4 174
|
5 237
|
31 138
|
42 953
|
40 836
|
|
| Total Liabilities |
62 099
N/A
|
85 193
+37%
|
121 493
+43%
|
54 534
-55%
|
30 421
-44%
|
13 936
-54%
|
39 788
+186%
|
150 242
+278%
|
175 591
+17%
|
233 020
+33%
|
290 886
+25%
|
218 743
-25%
|
|
| Equity | |||||||||||||
| Common Stock |
635
|
4 191
|
5 891
|
9 242
|
9 328
|
9 328
|
9 328
|
9 328
|
9 404
|
9 404
|
9 404
|
10 076
|
|
| Retained Earnings |
47 582
|
51 516
|
76 036
|
133 994
|
170 591
|
151 644
|
123 561
|
111 634
|
115 590
|
126 893
|
135 729
|
159 437
|
|
| Additional Paid In Capital |
6 191
|
2 635
|
26 222
|
170 032
|
171 287
|
171 287
|
168 725
|
174 919
|
195 714
|
195 747
|
225 940
|
315 593
|
|
| Unrealized Security Profit/Loss |
701
|
1 162
|
0
|
69
|
0
|
631
|
823
|
897
|
1 011
|
1 870
|
1 036
|
40
|
|
| Other Equity |
0
|
0
|
2 725
|
45
|
123
|
58
|
31
|
344
|
3 276
|
7 457
|
14 513
|
18 065
|
|
| Total Equity |
53 707
N/A
|
57 180
+6%
|
110 874
+94%
|
313 245
+183%
|
351 083
+12%
|
331 569
-6%
|
300 822
-9%
|
295 328
-2%
|
322 974
+9%
|
337 632
+5%
|
384 550
+14%
|
503 132
+31%
|
|
| Total Liabilities & Equity |
115 806
N/A
|
142 373
+23%
|
232 367
+63%
|
367 779
+58%
|
381 504
+4%
|
345 505
-9%
|
340 610
-1%
|
445 570
+31%
|
498 565
+12%
|
570 652
+14%
|
675 436
+18%
|
721 876
+7%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
8
|
8
|
12
|
18
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
20
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
